Lifestyle habits and bladder cancer prognosis: effects by tumour stage and molecular subtype.
Non-muscle invasive bladder cancer patients (NMIBC) with T1 tumours or genomically unstable/squamous-cell-carcinoma-like molecular subtypes have a high risk of recurrence and muscle-invasive progression, the latter being a life-threatening condition. This project will provide insight in whether associations of smoking, body weight, physical activity, and fruit and vegetable consumption with NMIBC outcomes are mediated and/or modified by tumour stage and molecular subtype. Our ultimate aim is to provide NMIBC patients with tailored advice concerning their lifestyle to enable them to influence their prognosis.
Collaboration between Radboudumc (Project Leader Alina Vrieling, Principal Investigator Bart Kiemeney) and Erasmus MC (Principal Investigator Dr. Arno van Leenders)
Related news items
Stofwisselkracht grant for Daan Panneman and Richard Rodenburg16 January 2020
Daan Panneman & Richard Rodenburg have been awarded a Stofwisselkracht grant for their proposal “CRISPR/Cas9 knock-in complementation in fibroblasts of mitochondrial disease patients”. Together with Omar Tutakhel & Jan Smeitink they will investigate the possibility of using CRISPR/Cas9 knock-in.read more
The PRIDE Study Evaluation of online methods of data collection16 January 2020
In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.read more
Laparoscopy reduces the number of adhesions but it is still too high14 January 2020
Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues.read more
Radboud Talks 2020 scientific pitch competition14 January 2020
The next edition of Radboud Talks will take place in the spring. During this academic pitch competition, young researchers will be given the opportunity to share their stories with a large audience. In a three-minute presentation, you will talk about your research in a fun and accessible manner.read more
Review Sanne Frambach accepted by Pharmacological Reviews13 January 2020
In this review entitled 'Brothers in arms: ABCA1 and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment', RIMLS researcher Sanne Frambach, describe the possibilities for stimulating cellular efflux.read more